Publication | Open Access
<i>PRKDC</i>: new biomarker and drug target for checkpoint blockade immunotherapy
58
Citations
31
References
2020
Year
PRKDC is not only a predictive biomarker but also a drug target for immune checkpoint inhibitors.
| Year | Citations | |
|---|---|---|
Page 1
Page 1